169 related articles for article (PubMed ID: 36650016)
1. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria.
Shragai T; Adegoke OJ; Ikwe H; Sorungbe T; Haruna A; Williams I; Okonkwo R; Onu K; Asekun A; Gberikon M; Iwara E; Abimiku A; Rufai A; Okposen B; Gidudu J; Lam E; Bolu O
BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650016
[TBL] [Abstract][Full Text] [Related]
2. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adverse effects following immunisation degree after the administration COVID-19 vaccine of different platforms.
Bermawi B; Donastin A; Sari NDK; Kurniasari DW; Adriansyah AA; Ferdiansyah MA; Rofananda IF; Surya PA
Med J Malaysia; 2024 Mar; 79(2):124-127. PubMed ID: 38553914
[TBL] [Abstract][Full Text] [Related]
4. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
[TBL] [Abstract][Full Text] [Related]
5. Post COVID-19 vaccination: AusVaxSafety survey participation and adverse events - a community-based regional Queensland study.
Hamilton E; Oversby S; Kitchener S; Ratsch A
Aust N Z J Public Health; 2022 Dec; 46(6):738-744. PubMed ID: 36190203
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
7. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
Puspitarani F; Sitaresmi MN; Ahmad RA
Front Public Health; 2022; 10():999354. PubMed ID: 36388348
[TBL] [Abstract][Full Text] [Related]
8. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
9. Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study.
Omoleke SA; Getachew B; Isyaku A; Aliyu AB; Mustapha AM; Dansanda SM; Kanmodi KK; Abubakar H; Lawal ZI; Kangiwa HA
BMC Health Serv Res; 2022 Jun; 22(1):741. PubMed ID: 35658941
[TBL] [Abstract][Full Text] [Related]
10. A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.
Uzochukwu BSC; Okeke C; Shuaib F; Torres-Rueda S; Vassall A; Jit M; Nonvignon J; Uzochukwu AC; Ruiz F
Health Res Policy Syst; 2024 Jun; 22(1):73. PubMed ID: 38926716
[TBL] [Abstract][Full Text] [Related]
11. Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records.
Ishaku SG; Umeh G; Adzu B; Onimisi A; Dauda M; Iyal HA; Iliyasu N; Sunday DJ; Daikwo J; Yates SM; Ibrahim II; Samaila LH; Abdullahi B; Parom SK; Maiwashi KY; Zakari F; Nuhu KS
Pan Afr Med J; 2021; 40():268. PubMed ID: 35251462
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of adverse events following immunisation in Australia annual report, 2021.
Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926649
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
14. Vaccine Safety: Assessing the Prevalence and Severity of Adverse Events Following COVID-19 Vaccination amongst Healthcare Workers in Tertiary Health Facilities in Nigeria.
Azees AS; Fasiku MM; Isa A; Ezenwoko AZ; Ahmed A; Temitayo-Oboh AO; Utulu R; Adeniyi MA; Musa A; Alo C; Ibrahim UM; Imhonopi GB; Adesoye OO; Okeke IM; John GT; Ayinla AY
Niger Postgrad Med J; 2024 Jan; 31(1):1-7. PubMed ID: 38321791
[TBL] [Abstract][Full Text] [Related]
15. Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline.
Laemmle-Ruff I; Lewis G; Clothier HJ; Dimaguila GL; Wolthuizen M; Buttery J; Crawford NW
Front Public Health; 2022; 10():1053637. PubMed ID: 36408022
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
Gold MS; Lincoln G; Cashman P; Braunack-Mayer A; Stocks N
Vaccine; 2021 Jan; 39(2):332-342. PubMed ID: 33279317
[TBL] [Abstract][Full Text] [Related]
17. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.
Bhandari B; Rayamajhi G; Lamichhane P; Shenoy AK
Biomed Res Int; 2022; 2022():2911333. PubMed ID: 36017393
[TBL] [Abstract][Full Text] [Related]
18. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
Glover C; Crawford N; Leeb A; Wood N; Macartney K
Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
[TBL] [Abstract][Full Text] [Related]
19. Leveraging COVID-19 Vaccine Safety Monitoring in Ethiopia and Pakistan to Enhance System-Wide Safety Surveillance.
Hagos AA; Sahile Z; Ahmed W; Phanouvong S
Glob Health Sci Pract; 2024 Feb; 12(Suppl 1):. PubMed ID: 38216210
[TBL] [Abstract][Full Text] [Related]
20. Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
Blau EF; Balakrishnan MR; Sköld H; Santhana Gopala Krishnan RS; Lundquist P; Pal S; Gidudu JF
MMWR Morb Mortal Wkly Rep; 2023 Dec; 72(49):1321-1326. PubMed ID: 38060432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
